IPO Premiums
IPO calendar
MPMONOPHARMAListed

Mono Pharmacare Limited

Book Built Issue IPO · NSE

Price band
₹26 - ₹28
Lot size
4,000 shares
Issue amount
₹14.84 cr
Total subscription
13.47×
Current price₹8.9
Listing price ₹29
Watch live price ↗
Opens
28 Aug 2023
Closes
30 Aug 2023
Allotment
4 Sept 2023
Listing
7 Sept 2023

Offer at a glance

Issue overview

Issue size
53,00,000 shares
Face value
₹10 per share
Minimum investment
₹1,04,000
Fresh issue
₹14.84 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
NSE
Maximum investment
₹1,12,000
Issue type
Book Built Issue IPO
Shares before issue
1,23,68,564
Shares after issue
1,76,68,564

Lot sizes

CategoryLotsSharesAmount
RETAIL14,000₹1,12,000
HNI28,000₹2,24,000

Share reservation

Retail42.72%
NII(HNI)42.64%
QIB9.43%
Market Maker5.21%

Subscription & GMP

Subscription by category

Total subscribed13.47×

Missing multiples are calculated from bids and offered shares when available.

QIB10.89×
NIB8.12×
RETAIL19.39×

GMP history

01219 Mar: ₹24 Apr: ₹27 Nov: ₹2
19 Mar₹27 Nov

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs1.415.24
RETAIL6.34122.89
NIB6.3351.37

Financial performance

Company financials

in Lakhs · Reported periods may include interim results.

Revenue & profitin Lakhs
01,0002,0003,0004,000Mar 2023 · Revenue: 0Mar 2023 · Profit after tax: 0Mar 2023Mar 2022 · Revenue: 3,710.27Mar 2022 · Profit after tax: 35.09Mar 2022Mar 2021 · Revenue: 2,837.83Mar 2021 · Profit after tax: 9.51Mar 2021Mar 2020 · Revenue: 1,168.9Mar 2020 · Profit after tax: 1.99Mar 2020
RevenueProfit after tax

Key performance indicators

MetricValues
EPS1.99
ROE9.01
ROCE10.34
RONW9.01
PRE IPO(PE)0
POST IPO(PE)40

Values and labels as reported in the issue data.

Company information

Company profile

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.

Promoters

Panilam Lakhatariya

Supal Lakhatariya

Registrar & documents

Lead manager

Unistone Capital Private Limited

Registered office

1A, Krinkal Apartment Opp. Mahalaxmi Temple, Paldi Ahmedabad -380007

+91 99780 41356

[email protected]Company website ↗

Understanding MONOPHARMA IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.